Praveen Kumar Singh

About

I am microbiologist and immunologist specializing in T-lymphocyte development and Myeloid Derived Suppressor Cells(MDSCs). I have completed my Ph.D. in Medical Microbiology from the University of Delhi in July 2023, focusing my thesis on the "Role of myeloid-derived suppressor cells in regulating T cells in pemphigus vulgaris".
My academic journey began at Banaras Hindu University, where he earned his B.Sc. in Chemistry (2008-2011) and M.Sc. in Biotechnology (2011-2013). My master's dissertation involved computational identification and characterization of WRKY gene family members in Phaseolus Vulgaris L.
Throughout My career, I have received numerous awards and fellowships, including grants from FIMSA, IUIS, ISHAM and the Immunology Foundation. I was selected as one of ten young immunologists globally for an exclusive opportunity to meet Nobel Prize winners at the 18th International Congress of Immunology 2023 in South Africa.
My research interests focus on T-lymphocyte development, antibody repertoire generation in infection and autoimmunity, and myeloid-derived suppressor cells in relation to therapeutic strategies for infectious and autoimmune diseases. I have contributed to multiple publications in peer-reviewed journals, covering topics such as pemphigus vulgaris, COVID-19, fungal infections, and immunological responses in various diseases.

Employment

• University College of Medical Sciences Scientist
  2024 - Present
• University College of Medical Sciences Senior Research Fellow
  2020 - 2024
• University College of Medical Sciences and Guru Teg Bahadur Hospital PhD Student
  2016 - 2023

Education

• Banaras Hindu University B.Sc. (Hons.)
  2008 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (27)

• Role of myeloid-derived suppressor and Th17/Treg cells in post-COVID-19 Rhino-Orbital mucormycosis cases
  Immunopharmacology and Immunotoxicology 2025 DOI: 10.1080/08923973.2024.2437482
  +Save
• Mucormycosis in Diabetes: A Suggested Role of Th17 and T Regulatory Pathways
  Infectious Diseases in Clinical Practice 2024 DOI: 10.1097/IPC.0000000000001381
  +Save
• Role of regulatory T cells in pathogenesis and therapeutics of pemphigus vulgaris and bullous pemphigoid
  Regulatory T cells and Autoimmune Diseases 2024 DOI: 10.1016/B978-0-443-13947-5.00028-2
  +Save
• Role of regulatory T cells in pathogenesis and therapeutics of pemphigus vulgaris and bullous pemphigoid
  Regulatory T Cells and Autoimmune Diseases 2024 DOI: 10.1016/b978-0-443-13947-5.00028-2
  +Save
• COVID associated fungal sinusitis: An experience from a tertiary care hospital
  Clinical Otolaryngology 2023 DOI: 10.1111/coa.14061
  +Save
• Deregulated phenotype of autoreactive Th17 and Treg clone cells in pemphigus vulgaris after in-vitro treatment with desmoglein antigen (Dsg-3)
  Immunobiology 2023 DOI: 10.1016/j.imbio.2023.152340
  +Save
• Immunogenicity of measles-rubella vaccine administered under India's Universal Immunization Programme in the context of measles-rubella elimination goal: A longitudinal study
  Indian Journal of Medical Research 2023 DOI: 10.4103/ijmr.IJMR_4113_20
  +Save
• Implications of CD45RA and CD45RO T cell subsets in patients of chronic rhinosinusitis with nasal polyposis infected with Aspergillus flavus
  Scandinavian Journal of Immunology 2023 DOI: 10.1111/sji.13318
  +Save
• Incompetent memory immune response in severe COVID-19 patients under treatment
  Heliyon 2023 DOI: 10.1016/j.heliyon.2023.e20590
  +Save
• Low monocytic HLA-DR expression in critically ill patients of sepsis: An indicator for antimicrobial and/or immunomodulatory intervention
  Transplant Immunology 2023 DOI: 10.1016/j.trim.2023.101942
  +Save